Member Info for unvrkw

It looks like we all spent the day assessing spirit levels!! I visited a big tesco store, only had the gin in store, standard bottle and no other types. No rum, vodka and limited edition. The asda I visited had non, both big stores but neither had a great deal. I don't think it was due to lots been sold but at this time they are not stocked here. I assume if sales go well them it hopefully will widen.

I think the business will have had their best Christmas for some time. People bought premium brands on many items including liquor which is at a good price. All feedback seems good for the products, good, compariable price and I see no reason why this company cannot consolidate its costs and then move forward. Supply is an issue, however if this supply is due to tesco and asda etc coming first then acceptable for a period.

Can see this now increasing over the next two weeks, smallish amounts everyday as belief of possible validation and success comes closer. Shares in issue good, making a profit and cash raised to support both CD 4 and other products coming to market. I think as part of a portfolio this is a good mix, recommended and great potential.

if CD4 is validated and continues its trials past then i assume from what i read this has great potential and the market is already forming. i believe as written prior this could be a huge stock in 2014 based around CD4.

I note the Blackwood gin limited addition really is! Only 200k bottles made, limited on Shetland. Big seller is the rum, lots of it and well received. Vodka lots to compete against, I just hope Xmas went well at tesco so they continue to list, feels the products need more air time and the. Diageo come along and sweep them up for 20 million. Let me know how the visit goes.

  The Board has increased confidence in successfully completing the three-batch validation and, given the proximity to Christmas, we will provide a further update early in the New Year. 

Looking through the reviews and the sites where the products can be bought the blackwoods gin, redleg rum and the vodkas really stand out as great quality. The black vodka has a bit of an image problem dating back to the 90s however all the reviews talk of great quality and high marks. Biggest issue seems to be supply and where they can be bought. A number of sites are out of stock or people asking where to buy them from. Great premium investment, good, experienced man at the helm that can hopefully take this forward. Interesting investment, great potential, hopefully a Christmas momentum on their side that will be showing break even very soon.

whats their exposure like in US, see some data on some US cities and it won an award but assume great market potential here?

i used to own some premier foods, sold them at a profit and got out due to the ups and downs being too big for me. however always used to look at the shelves and question availability etc. now i have my new product and area of the supermarkets to look at. vodka and gin etc. will facebook the black one about and encourage sales!! looked on the internet for tesco and couldnt see it being sold but good start if in many stores and growing.

i bought mine this morning at the 1.8 mark and only seconds later it traded up slightly, not sure if this is a mix up or someone else? i think we shall see a trading update if going better than expected but not any more than that. there are so many areas these products can be sold including the big 5, currently tesco is shelved with little variety bar the big few vodka makers and maybe there is a great oppourtunity, certainly drinking less premium is going up and not down.

there was no update last year but i assume the company wasnt as well represented in the different markets etc that they was anything to go off. premium i think will work, awarding winning also. trading updates have started today and will show up to date, modern, premium businesses did well, (J Lewis). i think if things have gone well anytime next week, new year was only a day ago but the business is in tesco throughout which helps. just bought into this stock today, another difference/change on the rest of my stocks, totally different area. premium spirits etc are increasing significantly over the next few years in china etc and if these guys can be a small part of it then great.

It will probably be the George Eliot NHS bid that is mentioned within the RNS. No share for us, all going to the institutes and over 90% shares already voted in favour, they certainly must have a great business case. Likewise I have some fox, odx and ATC on break even or positive territory, would love to get another 10 to 15% out of them by the placing date, see a dip and then take advantage but I cannot see this now going anywhere near 30 pence again. If it did I would sell up the other and drive in. Hintchinbrooke still confirmed to break even and debt down, all others making a solid step towards profit n 2014 and the placing is for cash towards growth not to pay off debts. It's recognised in the price, Sunday times will open this share up a little more, shame. Up around 25% in holding, happy to sit and see this rise. Around 180 million shares in issue is not the end of world, worse case. If the private sector takes off and continues as is, circle is a billion pound company in 5 years.

what did it actual say in ST, missed that one. still have my original holding in here and about 15% up, the rest sold at around 140% gain and moved. will we get a placement oppourtunity or institues only? i would be happy to buy in some more if allowed

and certainly 2015 as the test are qualified further and go on full sale, as the board state, a step change in the business that will result in significant share holder value.

Not until the business makes money and can create dividend will it be announced. At this time none expected but could change.

I think on our next update we will see upwards towards 1 million on the order book. In context of the few months that fox have been selling we have seen an increased order book and already some invoiced. It has also been mentioned of Orders coming from repeat customers. By end of 2014 I think the orders will be in the millions, global economy is improving, expected growth in 2014 and fox marble will capitalise. As Italian polishing gets more expensive the plant will come on line. Anyone know what marble margins are? Appreciate the price is rather stable, any thoughts. I assume costs in the countries of operation are relatively cheap?

Everyone wants marble. In 2014 the global market will boom, asia and US will see far more cash available and rich people will buy marble. It will be the quarry that is worth the cash, cheap processing and shipping globally. As indicated a change in approach to increasing product to meet demand. Diverting cash to stay within budgets and meet orders. I think orders in 2014 will boom, massive increase in volume and plant completed by year end. Dividend in 2015, all next years money will be used to finance expansion. Economy will boom for at least 10 years giving great demand and a customer for years to come.

America is going to have twenty years of shale gas booming and I suspect aht will be there in a big way to take advantage. I have had these shares in the past but not at the moment, good hold, at least £10 as the US goes to new levels.

Omega Diagnostics Group Plc (LON:ODX) had its corporate rating reiterated by analysts at FinnCap. FinnCap currently has a GBX 25 ($0.41) price target on the stock.

they have stated an update in early jan 2014, i would get in before this date, expect this to be strong and lead to suggestions of next steps hence increase in price. i assume the language used about CD4 suggests that success is very likely and the test are whilst can go wrong a formality (hopefully). "Trading in the first half of the year is in line with management's expectation. The core business has held up as certain headwinds have been mitigated with growth in other parts of the business. We recognise that our ability to make a step change of our future growth is highly predicated on successful outcomes of both our CD4 and IDS-iSYS projects and we are at sufficiently advanced stages with both projects to be very confident that both will deliver significant shareholder value in the next financial year